|Articles|September 19, 2012

NattoPharma Secures U.S. Patent for Vitamin K2 in Heart-Healthy Food

NattoPharma says that the patent gives it “broad coverage” in the use of vitamin K2, also known as menaquinones, in these types of products.

NattoPharma ASA (Oslo, Norway) has obtained a U.S. patent covering the use of vitamin K2 in food products, including dietary supplements, for the purpose of “maintaining, optimizing, strengthening, or promoting cardiovascular health,” the company reports.

NattoPharma says that the patent gives it “broad coverage” in the use of vitamin K2, also known as menaquinones, in these types of products.

“The approval of the patent represents a milestone for NattoPharma and our partners in the U.S. market,” says company CEO Hogne Vik, PhD. “This will strengthen NattoPharma’s global IPR-platform and improve our competitive position in the United States within the food supplement market as well as the functional food market.”

The patent is No. 09/850,804: “Vitamin K2 Containing Food Product.” NattoPharma is the supplier of branded vitamin K2 ingredient MenaQ7.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.